Filing Details
- Accession Number:
- 0001593968-20-002243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-24 16:09:50
- Reporting Period:
- 2020-11-23
- Accepted Time:
- 2020-11-24 16:09:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 887359 | Vericel Corp | VCEL | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1220363 | Md L Robert Zerbe | C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-23 | 15,000 | $3.74 | 34,295 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-23 | 15,000 | $2.76 | 49,295 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-23 | 17,500 | $23.55 | 31,795 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-23 | 15,000 | $0.00 | 15,000 | $3.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-11-23 | 15,000 | $0.00 | 15,000 | $2.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-03-20 | No | 4 | M | Direct | |
| 0 | 2026-05-04 | No | 4 | M | Direct |
Footnotes
- These options, representing the right to purchase a total of 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015 and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
- These options, representing the right to purchase a total of 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Billionaire Hedge Funds
